Summit on Controlled Substances – Regulation, Litigation, and Enforcement

Lynn Mehler served as both co-chair and speaker at the American Conference Institute's (ACI) Summit on Controlled Substances – Regulation, Litigation, and Enforcement.

The conference featured sessions on the challenges those in the health care industry are facing from federal and state authorities. The session Lynn spoke during, entitled "Dissecting DEA's Quota Reduction Regulation," discussed how companies can effectively navigate the Drug Enforcement Administration's (DEA) regulation and remain compliant.

Learn More: Summit on Controlled Substances – Regulation, Litigation, and Enforcement


Back To Listing
Loading data